AKTXNasdaq CM

Akari Therapeutics, Plc

7.87+5.35%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tier
Alert levelinsufficient_liquidity

Tier and alert level are a summary. Unlock AKTX to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

−0.37%, downReturn · 1w
−6.97%, downReturn · 1m
−50.58%, downReturn · 3m
−77.77%, downReturn · 1y
−84.13%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 45.

RSI (14)45.28Neutral
MACD / signal-0.58 / -0.76, favorable readingAbove signal line
SMA 509.81, caution readingPrice below
SMA 20010.41, caution readingPrice below
EMA 208.06, caution readingPrice below
ADX (14)18.44Rangebound
+DI / −DI12.12 / 17.90−DI leading
ATR (14)0.73, flagged reading9.3% of price — elevated daily swings
Stochastic %K85.53, flagged readingOverbought zone
Bollinger bands (20)6.97 – 8.34Inside bands
ROC (10)1.81, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking AKTX reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock AKTX: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get AKTX + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock AKTX